Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business Update
Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company, has announced it will report financial results and provide a business update for its third quarter ended August 31, 2024, on Thursday, October 10 at 8:30 a.m. ET. The conference call will be hosted by Paul Lévesque, President and CEO, joined by other management team members including Philippe Dubuc, Christian Marsolais, and John Leasure.
Participants are encouraged to join the call at least ten minutes in advance. The webcast link and dial-in information have been provided. A replay of the call will be available until October 17, 2024, with toll-free and international dial-in numbers provided. An archived webcast will also be available on the Company's Investor Relations website under 'Past Events'.
Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX), un'azienda biofarmaceutica, ha annunciato che riporterà i risultati finanziari e fornirà un aggiornamento aziendale per il terzo trimestre terminato il 31 agosto 2024, giovedì 10 ottobre alle 8:30 a.m. ET. La chiamata in conferenza sarà ospitata da Paul Lévesque, Presidente e CEO, insieme ad altri membri del team dirigenziale, tra cui Philippe Dubuc, Christian Marsolais e John Leasure.
I partecipanti sono invitati a unirsi alla chiamata almeno dieci minuti prima. Il link per la diretta e le informazioni per la chiamata sono stati forniti. Una registrazione della chiamata sarà disponibile fino al 17 ottobre 2024, con numeri verdi e internazionali forniti. Un webcast archiviato sarà inoltre disponibile sul sito web delle Relazioni con gli Investitori dell'azienda sotto 'Eventi passati'.
Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX), una empresa biofarmacéutica, ha anunciado que informará los resultados financieros y proporcionará una actualización empresarial para su tercer trimestre que concluyó el 31 de agosto de 2024, el jueves 10 de octubre a las 8:30 a.m. ET. La llamada de conferencia será dirigida por Paul Lévesque, Presidente y CEO, acompañado de otros miembros del equipo directivo, incluidos Philippe Dubuc, Christian Marsolais y John Leasure.
Se anima a los participantes a unirse a la llamada al menos diez minutos antes. Se ha proporcionado el enlace de la transmisión y la información de marcación. Una repetición de la llamada estará disponible hasta el 17 de octubre de 2024, con números de marcación gratuita e internacional proporcionados. También estará disponible un webcast archivado en el sitio web de Relaciones con Inversores de la empresa bajo 'Eventos Pasados'.
Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX)은 생명공학 제약 회사로, 2024년 8월 31일에 종료된 3분기 재무 결과와 사업 업데이트를 보고할 것이라고 발표했습니다. 이 발표는 10월 10일 목요일 오전 8시 30분 ET에 있을 예정입니다. 컨퍼런스 콜은 Paul Lévesque, 사장 겸 CEO가 진행하며 Philippe Dubuc, Christian Marsolais, John Leasure를 포함한 다른 경영진도 함께할 것입니다.
참가자는 최소 10분 전에 통화에 참여할 것을 권장합니다. 웹캐스트 링크와 전화 접속 정보가 제공되었습니다. 통화의 재생은 2024년 10월 17일까지 사용할 수 있으며, 무료 및 국제 전화 접속 번호가 제공됩니다. 회사의 투자자 관계 웹사이트의 '과거 이벤트' 섹션에서도 아카이브된 웹캐스트를 이용할 수 있습니다.
Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX), une société bio-pharmaceutique, a annoncé qu'elle fera état des résultats financiers et fournira une mise à jour commerciale pour son troisième trimestre se terminant le 31 août 2024, le jeudi 10 octobre à 8h30 HE. L'appel conférence sera animé par Paul Lévesque, Président et CEO, accompagné d'autres membres de l'équipe de direction, dont Philippe Dubuc, Christian Marsolais et John Leasure.
Les participants sont invités à se joindre à l'appel au moins dix minutes à l'avance. Le lien du webinaire et les informations d'appel ont été fournis. Un enregistrement de l'appel sera disponible jusqu'au 17 octobre 2024, avec des numéros d'appel gratuits et internationaux fournis. Un webinaire archivé sera également disponible sur le site Web des relations avec les investisseurs de l'entreprise sous 'Événements passés'.
Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX), ein biopharmazeutisches Unternehmen, hat angekündigt, dass es die finanziellen Ergebnisse und ein Unternehmensupdate für das am 31. August 2024 endende dritte Quartal berichten wird, am Donnerstag, den 10. Oktober um 8:30 Uhr ET. Die Telefonkonferenz wird von Paul Lévesque, Präsident und CEO, geleitet, zusammen mit anderen Mitgliedern des Managementteams, darunter Philippe Dubuc, Christian Marsolais und John Leasure.
Teilnehmer werden ermutigt, mindestens zehn Minuten im Voraus an der Konferenz teilzunehmen. Der Webcast-Link und die Einwahlinformationen wurden bereitgestellt. Eine Wiederholung des Gesprächs ist bis zum 17. Oktober 2024 verfügbar, mit gebührenfreien und internationalen Einwahlnummern. Ein archivierter Webcast wird ebenfalls auf der Website der Unternehmensinvestorenbeziehungen unter 'Vergangene Veranstaltungen' verfügbar sein.
- None.
- None.
MONTREAL, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report financial results and provide a business update for its third quarter ended August 31, 2024, on Thursday, October 10 at 8:30 a.m. ET.
The call will be hosted by Paul Lévesque, President and Chief Executive Officer. He will be joined by other members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer and John Leasure, Global Commercial Officer who will be available to answer questions from participants following prepared remarks.
Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information can be found below.
| CONFERENCE CALL INFORMATION | |
| Conference Call Date | October 10, 2024 |
| Conference Call Time | 8:30 a.m. ET |
| Webcast link | https://edge.media-server.com/mmc/p/vy4y3hwc |
| Dial in | 1-888-513-4119 (toll free) or 1-412-902-6615 (international) |
| Access Code | 5313857 |
| CONFERENCE CALL REPLAY | |
| Toll Free | 1-877-344-7529 (US) / 1-855-669-9658 (Canada) |
| International Toll | 1-412-317-0088 |
| Replay Access Code | 2159194 |
| Replay End Date | October 17, 2024 |
| To access the replay using an international dial-in number, please select this link: https://services.choruscall.com/ccforms/replay.html | |
An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter).
Contacts:
Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
pdubuc@theratech.com
438-315-6608
Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800
FAQ
When will Theratechnologies (THTX) report its Q3 2024 financial results?
Who will host the Q3 2024 earnings call for Theratechnologies (THTX)?
How can investors access the Q3 2024 earnings call for Theratechnologies (THTX)?
Until what date will the replay of Theratechnologies' (THTX) Q3 2024 earnings call be available?
